Medical Devices
HeartBeam Launches Pilot Study for On-Demand 12-Lead ECG Patch Aimed at Ischemia Detection
HeartBeam Inc. has initiated a pilot study for its investigational on-demand 12-lead ECG patch in coronary artery disease patients, potentially expanding ambulatory cardiac monitoring into ischemia detection within a $2 billion market.
Oragenics Signs LOI to License CardioDialysis Technology for Brain Disorders
Oragenics Inc. has signed a letter of intent to license Sigyn Therapeutics' CardioDialysis blood purification technology, aiming to combine it with its intranasal neurosteroid candidate ONP-002 for a dual-modality approach to traumatic brain injury and neurodegenerative diseases.
HeartBeam Expands Concierge Cardiology Footprint with Atelier Health Agreement
HeartBeam Inc. has signed a commercial agreement with Beverly Hills-based Atelier Health, expanding its launch footprint into Southern California and completing its initial targeted markets for its cable-free 3D ECG technology.
Aclarion Expands Commercial Team Amid Triple-Digit Growth in Nociscan Utilization
Aclarion granted inducement stock options to its new Western U.S. Commercial Director as demand for its Nociscan platform surges, reflecting strong adoption of its AI-driven chronic low back pain diagnostic tool.
HeartBeam Targets Heart Disease with Advanced ECG Technology as Cardiovascular Deaths Surge
HeartBeam Inc. is developing next-generation ECG solutions to address the gap in early cardiac detection, as cardiovascular disease remains the leading cause of death in the U.S. with over 919,000 deaths in 2023.
SS Innovations Surpasses 10,500 Surgeries with SSi Mantra Robotic System, Signaling Growing Global Adoption
SS Innovations International announced that its SSi Mantra surgical robotic system has been used in over 10,500 procedures across 11 countries, highlighting the system's rapid adoption and potential to democratize robotic surgery.
Aclarion Expands Nociscan Use at Weill Cornell Medicine in New Trial on Disc Degeneration
Aclarion's second commercial agreement with Weill Cornell Medicine will deploy its Nociscan platform in a randomized controlled trial led by Dr. Roger Härtl, aiming to improve understanding and treatment of degenerative disc disease.
HeartBeam to Report Q1 Earnings, Update on Commercial Launch and AI Initiatives
HeartBeam Inc. will host a Q1 2026 earnings call to discuss financial results and provide updates on its limited commercial launch for arrhythmia assessment, extended-wear patch development, and AI programs, marking a pivotal moment for the company's cardiac care innovations.
NeuroOne Announces CFO Succession Plan as Ron McClurg Retires, Chris Volker Takes Over
NeuroOne Medical Technologies Corporation announced that CFO Ron McClurg will retire effective June 30, 2026, with current COO Chris Volker assuming the permanent CFO role, ensuring a smooth transition as the company advances its growth strategy.
Aclarion Reports 196% Surge in Nociscan Scans, Advances Reimbursement and Clinical Trials
Aclarion's Q1 2026 results show a 196% year-over-year increase in Nociscan scan volumes, driven by clinical adoption and payer coverage, with a strong cash position and upcoming CLARITY trial data expected in late 2026.
Regeneris Launches Flexlift™, an Office-Based Face and Neck Lift with Minimal Downtime
Regeneris introduces Flexlift™, a face and neck rejuvenation procedure developed by Dr. Edwin Ishoo that uses local anesthesia, reduces recovery time, and costs less than traditional facelifts.
VolitionRx Achieves Technical Milestone in Sepsis Detection with Finger-Prick Prototype
VolitionRx announced a prototype that can detect nucleosomes in capillary blood from sepsis patients, potentially enabling point-of-care testing and expanding access in regions with limited lab infrastructure.
OMRON Healthcare to Donate 3,000 Blood Pressure Monitors for May Measurement Month 2026
OMRON Healthcare supports May Measurement Month 2026 by donating 3,000 blood pressure monitors, including AFib-detecting models, to enhance global hypertension screening and awareness.
NeuroOne to Report Fiscal Q2 2026 Financial Results on May 12, Highlights Minimally Invasive Neurological Tech
NeuroOne Medical Technologies will announce its fiscal second quarter 2026 financial results on May 12, 2026, with a focus on its FDA-cleared electrode and ablation systems that aim to reduce hospitalizations and improve outcomes for neurological disorders.
Ventripoint's AI-Powered Cardiac Imaging System Submitted for Expedited Approval in China
Ventripoint Diagnostics announced that its VMS+ 4.0 system has been submitted for regulatory approval in China via an expedited 'green channel' pathway, potentially accelerating access to AI-driven cardiac diagnostics in a market with 330 million cardiovascular patients.
Aclarion Appoints Daniel Keefe as Commercial Director to Drive Western U.S. Expansion of Nociscan
Aclarion hires Daniel Keefe to lead Western U.S. commercial efforts, capitalizing on triple-digit growth in Nociscan utilization for chronic low back pain diagnosis.
Medartis Shareholders Overwhelmingly Approve Board Proposals, Elect Yang Xu at AGM 2026
Medartis shareholders approved all board proposals with over 90.9% support and elected Yang Xu to the board, signaling strong confidence in the company's governance and strategic direction.
HeartBeam Announces Public Offering to Fund Cardiac Technology Commercialization and AI Development
HeartBeam Inc. is launching a public offering to finance the commercialization of its FDA-cleared 12-lead ECG system and advance AI initiatives for cardiac care.
Polyrizon Secures $3.5 Million in Funding to Advance Intranasal Protective Technology
Polyrizon Ltd. has raised $3.5 million through a registered direct offering and private placement to fund development of its nasal spray hydrogel technology designed to create protective barriers against viruses and allergens.
Compact Proton Therapy Systems Promise Greater Accessibility for Cancer Patients
Innovative compact proton therapy systems are reducing equipment size and costs, potentially making this precise cancer treatment more accessible to patients who previously couldn't access it due to traditional systems' limitations.
Nutriband CEO Discusses AVERSA Technology's Role in Addressing Opioid Crisis on Podcast
Nutriband Inc. CEO Gareth Sheridan highlighted the company's AVERSA abuse-deterrent transdermal technology on a podcast, emphasizing its potential to reduce misuse of high-risk drugs like fentanyl while maintaining patient access.
BioElectronics Expands ActiPatch to Taiwan Through Aphrodite Medical Group Partnership
BioElectronics Corporation's expansion of its FDA-cleared ActiPatch device to Taiwan through distributor Aphrodite Medical Group represents a significant shift toward drug-free pain management alternatives in Asian healthcare markets.
Aclarion Authorizes $2.5 Million Stock Buyback, Signaling Confidence in Nociscan Growth
Aclarion's board-approved share repurchase program highlights the company's disciplined capital management and belief that its stock is undervalued despite the ongoing clinical adoption of its Nociscan platform for chronic back pain diagnosis.
Nephros Targets $25 Million Opportunity in Greater New York with New Regional Sales Leader
Nephros appoints Dana Cunningham as dedicated regional sales leader to accelerate growth in the Greater New York market, which it estimates represents a $25 million annual addressable opportunity for point-of-use filtration and services.
HeartBeam Closes $10 Million Public Offering to Accelerate Cardiac Tech Commercialization
HeartBeam Inc. raised $10 million in a public offering to fund the commercialization of its FDA-cleared 12-lead synthesized ECG system and other cardiac technologies.
HeartBeam Closes $10M Public Offering to Fund Commercialization of ECG Technology
HeartBeam raised $10 million in a public offering to advance its FDA-cleared 12-lead synthesized ECG system and heart attack detection technologies, positioning the company for expanded market reach.
Ocumetics Reports Life-Changing Six-Month Results from First-in-Human Study of Accommodating Intraocular Lens
Ocumetics Technology Corp. announced that six-month postoperative results from its first-in-human study of the Ocumetics Accommodating Intraocular Lens show continued vision improvements and meaningful quality-of-life enhancements for patients, with plans to advance to Group Two surgeries.
BioXgen Seeks Crowdfunding Investment for Cardiac Patch Targeting Post-Surgery Complication
BioXgen is launching a Regulation Crowdfunding investment round and hosting a webinar to demonstrate its cardiac patch designed to prevent postoperative atrial fibrillation, a common complication affecting nearly half of open-heart surgery patients.
HeartBeam Ranked Second Globally in Portable ECG Innovation
HeartBeam has been recognized as a top global innovator in portable ECG technology, ranking second worldwide in 12-lead ECG innovation among 243 companies analyzed, highlighting the company's growing influence in remote cardiac care solutions.
HeartBeam Ranked Second Globally in 12-Lead ECG Innovation by PatentVest Report
HeartBeam Inc. has been recognized as a top global innovator in portable ECG technology, ranking second worldwide in 12-lead ECG innovation among 243 companies evaluated, highlighting the company's growing influence in remote cardiac care technology.